2019
DOI: 10.1016/j.ygyno.2019.02.027
|View full text |Cite
|
Sign up to set email alerts
|

Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
61
1
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 73 publications
(74 citation statements)
references
References 34 publications
2
61
1
2
Order By: Relevance
“…Older studies suggest that cytokeratin staining in lymph nodes in patients with endometrial carcinoma and otherwise no known metastasis is a predictor of recurrence27; however this is not supported by ours and other studies 21–23. We have shown that no patients with endometrial carcinoma and ITCs and no adjuvant treatment recurred in a median follow-up of 32.6 months.…”
Section: Discussioncontrasting
confidence: 78%
See 2 more Smart Citations
“…Older studies suggest that cytokeratin staining in lymph nodes in patients with endometrial carcinoma and otherwise no known metastasis is a predictor of recurrence27; however this is not supported by ours and other studies 21–23. We have shown that no patients with endometrial carcinoma and ITCs and no adjuvant treatment recurred in a median follow-up of 32.6 months.…”
Section: Discussioncontrasting
confidence: 78%
“…The management of patients with ITCs is controversial and, depending on the center, some patients receive adjuvant treatment on the basis of the presence of ITCs, while others are observed. Studies examining patients with endometrial carcinoma and ITCs have shown that patients with ITCs often receive adjuvant therapy with the percentage of patients receiving adjuvant treatment ranging from 57–87%,18 21 22 so the assessment of the clinical significance of ITCs is confounded 23. Due to the retrospective nature of detecting ITCs in our study, patients were not known to have ITCs at the time of diagnosis and their presence was not factored into treatment decisions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because, lymph node metastasis ranges from less than 1% in low grade patients without myometrial invasion to >25% in patients with high grade tumors and deep invasion [58]. Appropriate risk stratification is essential for adequate therapeutic interventions.…”
Section: Adjuvant Radiationmentioning
confidence: 99%
“…Accumulating data suggested that sentinel node mapping improves detection rate of positive nodes in comparison to lymphadenectomy, thanks to the application of ultrastaging on sentinel nodes harvested. It is estimated that the adoption of sentinel node mapping (and ultrastaging) increase positive node detection rate of more than 30%, being ultrastaging able to detect low volume disease not detectable with conventional histological examination [5].…”
Section: Sentinel Node Mapping In Endometrial Cancermentioning
confidence: 99%